Work

Hepatosplenic T cell lymphoma responsive to 2′‐deoxycoformycin therapy

Year: 2010

Type: article

Abstract: Hepatosplenic T cell lymphoma (HSTL) is a rare condition usually with an aggressive course and a poor prognosis even after extensive treatment. We describe here a patient who presented with hemophagocytosis. The lymphoma had unusual phenotypic features, an indolent course and responded to 20-deoxycoformycin therapy as a single agent. We suggest that this therapy be used in further cases as part of the treatment strategy.

Source: American Journal of Hematology

DOI: 10.1002/ajh.21774

Authors: Michael Bennett, Estella Matutes, Philippe Gaulard

Institutions: Emek Medical Center, Royal Marsden Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Chonnam National University, Fondation de France